Mark Murcko - Net Worth and Insider Trading

Mark Murcko Net Worth

The estimated net worth of Mark Murcko is at least $7 Million dollars as of 2024-05-27. Mark Murcko is the Director of Relay Therapeutics Inc and owns about 996,952 shares of Relay Therapeutics Inc (RLAY) stock worth over $7 Million. Details can be seen in Mark Murcko's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark Murcko has not made any transactions after 2022-09-08 and currently still holds the listed stock(s).

Transaction Summary of Mark Murcko

To

Mark Murcko Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Murcko owns 1 companies in total, including Relay Therapeutics Inc (RLAY) .

Click here to see the complete history of Mark Murcko’s form 4 insider trades.

Insider Ownership Summary of Mark Murcko

Ticker Comapny Transaction Date Type of Owner
RLAY Relay Therapeutics Inc 2022-09-08 director

Mark Murcko Latest Holdings Summary

Mark Murcko currently owns a total of 1 stock. Mark Murcko owns 996,952 shares of Relay Therapeutics Inc (RLAY) as of September 8, 2022, with a value of $7 Million.

Latest Holdings of Mark Murcko

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RLAY Relay Therapeutics Inc 2022-09-08 996,952 6.82 6,799,213

Holding Weightings of Mark Murcko


Mark Murcko Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark Murcko has made a total of 2 transactions in Relay Therapeutics Inc (RLAY) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Relay Therapeutics Inc is the sale of 25,000 shares on September 8, 2022, which brought Mark Murcko around $748,750.

Insider Trading History of Mark Murcko

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark Murcko Trading Performance

GuruFocus tracks the stock performance after each of Mark Murcko's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Murcko is -9.05%. GuruFocus also compares Mark Murcko's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Murcko within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mark Murcko's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mark Murcko

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -13.86
Relative Return to S&P 500(%) -17.97

Mark Murcko Ownership Network

Ownership Network List of Mark Murcko

No Data

Ownership Network Relation of Mark Murcko


Mark Murcko Owned Company Details

What does Relay Therapeutics Inc do?

Who are the key executives at Relay Therapeutics Inc?

Mark Murcko is the director of Relay Therapeutics Inc. Other key executives at Relay Therapeutics Inc include See remarks Peter Rahmer , Vice President & Finance Thomas Catinazzo , and See Remarks Donald A Bergstrom .

Relay Therapeutics Inc (RLAY) Insider Trades Summary

Over the past 18 months, Mark Murcko made no insider transaction in Relay Therapeutics Inc (RLAY). Other recent insider transactions involving Relay Therapeutics Inc (RLAY) include a net sale of 20,412 shares made by Brian Adams , a net sale of 12,851 shares made by Thomas Catinazzo , and a net sale of 19,262 shares made by Donald A Bergstrom .

In summary, during the past 3 months, insiders sold 9,108 shares of Relay Therapeutics Inc (RLAY) in total and bought 0 shares, with a net sale of 9,108 shares. During the past 18 months, 188,690 shares of Relay Therapeutics Inc (RLAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 188,690 shares.

Relay Therapeutics Inc (RLAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Relay Therapeutics Inc Insider Transactions

No Available Data

Mark Murcko Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Murcko. You might contact Mark Murcko via mailing address: C/o Relay Therapeutics, Inc., 399 Binney Street, Cambridge Ma 02139.

Discussions on Mark Murcko

No discussions yet.